[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market. 2019-2023: Analyzer and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Latest Instrumentation, Competitive Strategies

June 2019 | 426 pages | ID: 2B979AD6E14EN
Venture Planning Group

US$ 4,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers of blood banking products by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis
  • Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.
  • Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment:
    • Blood Centers
    • Hospitals
    • Commercial/Private Laboratories
Current and Emerging Products
  • Analysis of current and emerging blood typing, grouping and infectious disease screening tests.
  • Review of automated and semi-automated analyzers.
Technology Review
  • Assessment of current and emerging technologies, and their potential applications for the blood banking market.
  • Comprehensive lists of companies developing or marketing new technologies and products, by test.
Strategic Recommendations
  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Contains 430 pages and 36 tables
I. INTRODUCTION

II. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests

1. BLOOD TYPING AND GROUPING TESTS

    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Blood Group Genotyping
    a. PCR
    b. PCR-RFLP
    c. AS-PCR or PCR-SSP
    d. Multiplex PCR
    e. Real Time PCR
    f. Sanger DNA Sequencing
    g. Pyrosequencing
    b. Microarrays
  BeadChip Array
  BloodChip
  Genome Lab SNP Stream
  Fluidic Microarray Systems
  TaqMan OpenArray
  MALDI-TOF-MS
  Mini-Sequencing
  3. Infectious Disease Screening Tests
    a. AIDS
  Structure and Composition
  Classification
  Origin of AIDS
  Animal Lentivirus Systems
  Virus Receptors
  HIV Infections in Humans
    Pathogenesis & Pathology
    Overview of Course of HIV Infection
  CD4T Lymphocytes and Memory Cells
  Monocytes and Macrophages
  Lymphoid Organs
  Neural Cells
  Viral Coinfections
    Clinical Findings
  Plasma Viral Load
  Pediactric AIDS
    Neurologic Disease
    Opportunistic Infections
    Protozoa
    Fungi
    Bacteria
  Viruses
  Cancer
  Immunity
  Laboratory Diagnosis
    Virus Isolation
    Serology
    Detection of Viral Nucleic Acid or Antigens
  Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
  Prevention, Treatment, And Control
    Antiviral Drugs
    Vaccines Against HIV
  Transmission of HIV in Blood Products
  HIV Transmission in Transplant and Artificial Insemination Recipients
  Diagnostic Tests
  Enzyme Immunoassay Interpretation
  Specificity, Sensitivity, and Predictive
Value of Enzyme Immunoassay
  Competition Assays
  Western Blot Technique
  Immuno-Fluorescence Assay (IFA)
  Radioimmunoprecipitation
  HIV-1/HIV-2 Combination Testing
  Methods of HIV-Antigen Detection
  Antigen Assays and Blood Screening
  Urine Tests
  DNA Probes
  Overview
  Quantitative Polymerase Chain Reaction
  In Situ PCR
  Needed Improvements
  Viral Load/Drug Resistance Testing
  Genotype and Phenotype Testing
  Blood Banking Considerations
    b. Hepatitis
  Hepatitis A
  Hepatitis B
    Structure and Composition
    Replication of Hepatitis B Virus
  Hepatitis C
  Hepatitis D (Delta Hepatitis)
  Hepatitis E
  Hepatitis G
  Hepatitis Virus Infections In Humans
    Pathology
  Clinical Findings
  Laboratory Features
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
  Virus-Host Immune Reactions
  Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta Agent)
  Vaccines and Drugs
    c. Cytomegalovirus
  Background
  Chorioretinitis
  Gastrointestinal
  Central Nervous System Disease
  Diagnostic Tests
  Vaccines and Drugs
    d. Syphilis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    e. West Nile Virus
  Background
  Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
    f. Parvovirus B19
  Microbiology
  Epidemiology
  Clinical Syndromes
    Erythema Infectiosum Slapped (cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in the Immunocompromised
    Perinatal Infections
  Diagnosis
  Treatment
    g. Creutzfeldt-Jakob’s Disease
  Background
  Transmission
  Diagnostic Tests
  Major Commercial and Academic Players
    Bayer
    Disease Sciences/BioTec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
  Drugs
  Vaccines
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  4. Pathogen Reduction
  5. Leukocyte Reduction
  Background
  Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
BioMerieux
Cepheid
Curtis Unyvero
Gen-Probe/Hologic
GenMark
Grifols
HTG
Immucor
Life Technologies
Nanosphere
Ortho-Clinical Diagnostics
Qiagen
Roche
Sarstedt
Siemens
Tecan
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
  1. Molecular Diagnostics
    a. Overview
    b. NAT
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
    a. Albumin
    b. Factor VIII
    c. Alpha-2 Antiplasmin
    d. Antithrombin III
    e. Factor IX
    f. Von Willebrand's Factor
    g. Fibrinogen
    h. t-PA
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

III. JAPAN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan
Thermo Fisher

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: Japan, Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
Japan, Facilities Performing Blood Bank Tests by Market Segment
Japan, Hospital Laboratories Performing Blood Bank Tests By Bed Size
Japan, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast by Market Segment
Japan, All Market Segments Blood Typing and Grouping Test Volume Forecast
Japan, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, Blood Banks Blood Typing and Grouping Test Volume Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
Japan, All Market Segments Infectious Disease Screening Test Volume Forecast
Japan, Blood Banks Infectious Disease Screening Test Volume Forecast
Japan, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
Japan, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
Japan, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
Japan, All Market Segments Blood Typing And Grouping Reagent Market Forecast by Major Test
Japan, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Japan, Blood Banks Blood Typing and Grouping Reagent Market By Major Test Forecast
Japan, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
Japan, All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Japan, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
Japan, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
Japan, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
Japan, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
Japan, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
Japan, Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier
Japan, CMV Blood Screening Market, Reagent Sales by Major Supplier
Japan, Syphilis Blood Screening Market, Reagent Sales by Major Supplier


More Publications